AUROPHARMA.NSAUROPHARMA.NSNSE
Loading
EBITDA as a percentage of revenue
3Y CAGR
+3.3%/yr
vs -5.6%/yr prior
5Y CAGR
-0.5%/yr
Recent acceleration
Acceleration
+9.0pp
Accelerating
Percentile
P36
Within normal range
vs 5Y Ago
1x
Modest growth
Streak
2 yr
Consecutive growthStable
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 20.29% | +2.1% |
| 2024 | 19.87% | +35.9% |
| 2023 | 14.62% | -20.5% |
| 2022 | 18.38% | -15.6% |
| 2021 | 21.78% | +4.7% |
| 2020 | 20.79% | +2.2% |
| 2019 | 20.34% | -12.3% |
| 2018 | 23.19% | -0.4% |
| 2017 | 23.27% | -0.0% |
| 2016 | 23.28% | - |